EA201501174A1 - Фармацевтический препарат для применения в эндорадионуклидной терапии - Google Patents
Фармацевтический препарат для применения в эндорадионуклидной терапииInfo
- Publication number
- EA201501174A1 EA201501174A1 EA201501174A EA201501174A EA201501174A1 EA 201501174 A1 EA201501174 A1 EA 201501174A1 EA 201501174 A EA201501174 A EA 201501174A EA 201501174 A EA201501174 A EA 201501174A EA 201501174 A1 EA201501174 A1 EA 201501174A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- solution
- application
- pharmaceutical preparation
- alpha
- endoradionuclide therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1075—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1051—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Saccharide Compounds (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Настоящее изобретение обеспечивает способ образования очищенного раствора как минимум одного излучающего альфа-частицы радионуклидного комплекса. Способ включает контактирование раствора излучающего альфа-частицы радионуклидного комплекса и как минимум одного дочернего нуклида с как минимум одним селективным связующим веществом для дочернего нуклида и последующее отделение раствора от селективного связующего вещества. Изобретение также обеспечивает способ удаления как минимум одного дочернего радионуклида из раствора, включающего как минимум один излучающий альфа-частицы радионуклидный комплекс. Способ включает контактирование раствора с как минимум одним селективным связующим веществом для дочернего нуклида.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1310028.4A GB201310028D0 (en) | 2013-06-05 | 2013-06-05 | Pharmaceutical preparation |
| PCT/EP2014/061743 WO2014195423A1 (en) | 2013-06-05 | 2014-06-05 | Pharmaceutical preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201501174A1 true EA201501174A1 (ru) | 2016-10-31 |
Family
ID=48805787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201501174A EA201501174A1 (ru) | 2013-06-05 | 2014-06-05 | Фармацевтический препарат для применения в эндорадионуклидной терапии |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US20160114063A1 (ru) |
| EP (1) | EP3003401B1 (ru) |
| JP (1) | JP6580559B2 (ru) |
| KR (1) | KR102321763B1 (ru) |
| CN (1) | CN105592863B (ru) |
| AP (1) | AP2015008894A0 (ru) |
| AU (1) | AU2014276885B2 (ru) |
| BR (1) | BR112015030298A2 (ru) |
| CA (1) | CA2914278C (ru) |
| CL (1) | CL2015003554A1 (ru) |
| CR (1) | CR20150642A (ru) |
| CU (1) | CU24535B1 (ru) |
| DK (1) | DK3003401T3 (ru) |
| DO (1) | DOP2015000294A (ru) |
| EA (1) | EA201501174A1 (ru) |
| ES (1) | ES2782624T3 (ru) |
| GB (1) | GB201310028D0 (ru) |
| HR (1) | HRP20200456T1 (ru) |
| IL (1) | IL242704B (ru) |
| LT (1) | LT3003401T (ru) |
| MA (1) | MA38650B1 (ru) |
| MX (1) | MX366028B (ru) |
| MY (1) | MY180717A (ru) |
| NI (1) | NI201500173A (ru) |
| PE (1) | PE20160215A1 (ru) |
| PH (1) | PH12015502715B1 (ru) |
| PL (1) | PL3003401T3 (ru) |
| PT (1) | PT3003401T (ru) |
| RS (1) | RS60091B1 (ru) |
| SA (1) | SA515370233B1 (ru) |
| SG (1) | SG11201509856RA (ru) |
| SI (1) | SI3003401T1 (ru) |
| TN (1) | TN2015000527A1 (ru) |
| UA (1) | UA120352C2 (ru) |
| WO (1) | WO2014195423A1 (ru) |
| ZA (1) | ZA201600027B (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201600158D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Purification method |
| GB201600161D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope purification method |
| MX2023008628A (es) | 2021-01-22 | 2023-09-22 | Bayer Ag | Anticuerpos lrrc15 y conjugados de los mismos. |
| NO347755B1 (en) * | 2021-10-21 | 2024-03-18 | Blue Wave Therapeutics Gmbh | Peptide-coupled alginate gels comprising radionuclides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5749042A (en) * | 1997-01-28 | 1998-05-05 | Battelle Memorial Institute | Bismuth generator method |
| GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
| JP5863640B2 (ja) * | 2009-04-29 | 2016-02-16 | バイオ−ラッド ラボラトリーズ インコーポレーティッド | 免疫複合体の精製 |
| GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
| GB201105298D0 (en) * | 2011-03-29 | 2011-05-11 | Algeta Asa | Pharmaceutical preparation |
-
2013
- 2013-06-05 GB GBGB1310028.4A patent/GB201310028D0/en not_active Ceased
-
2014
- 2014-06-05 AP AP2015008894A patent/AP2015008894A0/xx unknown
- 2014-06-05 KR KR1020157036893A patent/KR102321763B1/ko active IP Right Grant
- 2014-06-05 MY MYPI2015704399A patent/MY180717A/en unknown
- 2014-06-05 CU CU2015000174A patent/CU24535B1/es unknown
- 2014-06-05 TN TN2015000527A patent/TN2015000527A1/en unknown
- 2014-06-05 RS RS20200349A patent/RS60091B1/sr unknown
- 2014-06-05 MA MA38650A patent/MA38650B1/fr unknown
- 2014-06-05 PL PL14728571T patent/PL3003401T3/pl unknown
- 2014-06-05 SG SG11201509856RA patent/SG11201509856RA/en unknown
- 2014-06-05 SI SI201431535T patent/SI3003401T1/sl unknown
- 2014-06-05 PT PT147285712T patent/PT3003401T/pt unknown
- 2014-06-05 AU AU2014276885A patent/AU2014276885B2/en active Active
- 2014-06-05 CA CA2914278A patent/CA2914278C/en active Active
- 2014-06-05 LT LTEP14728571.2T patent/LT3003401T/lt unknown
- 2014-06-05 WO PCT/EP2014/061743 patent/WO2014195423A1/en active Application Filing
- 2014-06-05 ES ES14728571T patent/ES2782624T3/es active Active
- 2014-06-05 JP JP2016517608A patent/JP6580559B2/ja not_active Expired - Fee Related
- 2014-06-05 UA UAA201512920A patent/UA120352C2/uk unknown
- 2014-06-05 BR BR112015030298A patent/BR112015030298A2/pt active Search and Examination
- 2014-06-05 EP EP14728571.2A patent/EP3003401B1/en active Active
- 2014-06-05 EA EA201501174A patent/EA201501174A1/ru unknown
- 2014-06-05 MX MX2015016726A patent/MX366028B/es active IP Right Grant
- 2014-06-05 US US14/896,424 patent/US20160114063A1/en not_active Abandoned
- 2014-06-05 PE PE2015002566A patent/PE20160215A1/es unknown
- 2014-06-05 CN CN201480044621.8A patent/CN105592863B/zh active Active
- 2014-06-05 DK DK14728571.2T patent/DK3003401T3/da active
-
2015
- 2015-11-22 IL IL242704A patent/IL242704B/en active IP Right Grant
- 2015-12-03 SA SA515370233A patent/SA515370233B1/ar unknown
- 2015-12-04 DO DO2015000294A patent/DOP2015000294A/es unknown
- 2015-12-04 CR CR20150642A patent/CR20150642A/es unknown
- 2015-12-04 NI NI201500173A patent/NI201500173A/es unknown
- 2015-12-04 CL CL2015003554A patent/CL2015003554A1/es unknown
- 2015-12-04 PH PH12015502715A patent/PH12015502715B1/en unknown
-
2016
- 2016-01-04 ZA ZA2016/00027A patent/ZA201600027B/en unknown
-
2020
- 2020-03-19 HR HRP20200456TT patent/HRP20200456T1/hr unknown
-
2021
- 2021-05-04 US US17/307,857 patent/US20220023449A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201792613A1 (ru) | Модуляторы cot и способы их применения | |
| MX2019015604A (es) | Anticuerpos anti-tau y usos de los mismos en el tratamiento de una tauopatia. | |
| DK3024497T3 (da) | Fremgangsmåder og præparater til behandling af hjernesygdomme | |
| MX2021008755A (es) | Un anticuerpo anti-tau para usarse al tratar una tauopatia. | |
| EA201792612A1 (ru) | 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot | |
| EA201790475A1 (ru) | Способы лечения системной красной волчанки с использованием доменного антитела против cd28 | |
| EP3029581A4 (en) | PROCESSING PROGRAM, PROCESSING SYSTEM AND PROCESSING METHOD | |
| FI20165422A (fi) | Akkumoduuli, komponentit ja menetelmä | |
| SG11201701613YA (en) | System and process for analyzing, qualifying and ingesting sources of unstructured data via empirical attribution | |
| SG11201510362TA (en) | Apparatus, system, and method for processing information and program for the same | |
| HK1196988A1 (zh) | 信息處理終端、信息處理方法和信息處理程序 | |
| EP2972900A4 (en) | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM | |
| EA201501174A1 (ru) | Фармацевтический препарат для применения в эндорадионуклидной терапии | |
| KR20180084943A (ko) | 흡수제 및 그 제조 방법, 그리고 산성 화합물의 분리 회수 방법 | |
| GB201505427D0 (en) | Reconciliation processing system, method, and program | |
| DK3310428T3 (da) | System til sikker radioisotopfremstilling og -injektion | |
| EP2884380A4 (en) | OPERATING AID SYSTEM, OPERATING AID METHOD, AND COMPUTER PROGRAM | |
| CU20160069A7 (es) | Sistema multiparticulado para administrar drogas | |
| HK1212139A1 (en) | Nuclide identification method, nuclide identification system, and light neutron emitter | |
| EA201690446A1 (ru) | Лечение множественной миеломы | |
| EA201690445A1 (ru) | Лечение рака | |
| FR3001158B1 (fr) | Capsules gelifiees, et capsules gelifiees lyophilisees, renforcees, contenant des nano-objets et leurs procedes de preparation. | |
| EA201791126A1 (ru) | Химиоиммунотерапия, усиленная гаптенами, в виде персонализированной внутриопухолевой химиоиммунотерапии со сверхминимальным разрезом | |
| EP2980699A4 (en) | PROGRAM, INFORMATION PROCESSING SYSTEM AND PROGRAM MIGRATION METHOD | |
| GB201622269D0 (en) | The recovery method of high-performance parallel file storage system after malfunction |